Rankings
▼
Calendar
ANNX FY 2024 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena
ANNX
Annexon, Inc.
$713M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$3M
Operating Income
-$154M
Net Income
-$138M
EPS (Diluted)
$-1.01
Cash Flow
Operating Cash Flow
-$118M
Free Cash Flow
-$118M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$350M
Total Liabilities
$57M
Stockholders' Equity
$293M
Cash & Equivalents
$49M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$3M
$0
—
Operating Income
-$154M
-$144M
-7.2%
Net Income
-$138M
-$134M
-3.0%
← Q4 2023
All Quarters
Q1 2024 →